All articles tagged with #organ transplant
Scientists have engineered a 'universal' kidney that can be accepted across blood types by using enzymes to strip away donor antigens and convert the kidney to a type O-like profile. The enzyme-converted kidney survived for days in a brain-dead recipient, signaling progress toward reducing transplant wait times, though long-term viability and immune responses remain challenges that need further work.
A Houston surgeon, John Stevenson Bynon Jr., is federally charged with falsifying medical records to make five patients ineligible for liver transplant offers; three patients died and two later received transplants elsewhere. He pleaded not guilty, and a trial is set for April 6. If convicted, he could face up to five years in prison and fines up to $250,000 per count.
U.S. Health Secretary Robert F. Kennedy Jr. announced the termination of the Miami-based Life Alliance Organ Recovery Agency due to safety and fairness concerns, marking the first time a federal organization responsible for organ donation has been shut down, as part of broader efforts to overhaul the national transplant system.
The U.S. Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., announced major reforms to address systemic issues and unethical practices in the organ transplant system, including investigations revealing negligence and potential violations of donor rights, with strict corrective actions and increased oversight to ensure patient safety and restore trust.
Surgeons at Duke University successfully resuscitated a 'dead' heart on the operating table and transplanted it into a baby, demonstrating a new technique that could increase the donor pool and address ethical concerns by reanimating hearts outside the donor's body. Meanwhile, Vanderbilt University developed a method to preserve hearts without reanimation, further advancing transplant options. Both approaches aim to save more infant lives and expand the possibilities of organ donation.
Two men received kidneys from the same infected donor, leading to parasitic worm infections in both, which were successfully treated with ivermectin, highlighting the importance of screening for parasites like Strongyloides in organ transplants.
Researchers at the University of Queensland are developing a groundbreaking topical cream to prevent and treat skin cancers in organ transplant patients, with $344,000 in funding from the National Foundation for Medical Research and Innovation. The cream contains a novel drug that could prevent and treat early-stage skin cancers, particularly squamous cell carcinomas and Kaposi’s Sarcoma, which are risks for patients on immunosuppressive drugs. This development aims to progress the cream to clinical trials, offering a potentially life-changing treatment for transplant recipients.
Former NBA player Nate Robinson, a three-time slam dunk champion, has been battling kidney failure for years and is in urgent need of a transplant. Despite his fame and resources, Robinson has struggled to navigate the complex healthcare system and has been undergoing dialysis multiple times a week. His story highlights the challenges faced by many Americans, particularly Black Americans, in accessing timely and effective medical care. Robinson's journey has inspired many to offer help, and he remains hopeful for a transplant while raising awareness about kidney disease.
Memorial Hermann-Texas Medical Center in Houston has suspended its organ transplant program after allegations that a doctor manipulated patient records, making them ineligible for transplants. Dr. J. Steve Bynon Jr., a respected transplant surgeon, is accused of making inappropriate changes to the patient database, listing impossible characteristics that would disqualify patients from receiving transplants. The incident is under investigation by the U.S. Department of Health and Human Services.
Memorial Hermann-Texas Medical Center in Houston has halted liver and kidney transplants as it investigates "inappropriate changes" to patient records in a government database, which may have prevented patients from receiving new organs. The hospital is looking into alterations to liver donor acceptance criteria that effectively made candidates on the liver transplant waiting list inactive. The US Department of Health and Human Services is involved in the investigation, and the physician under scrutiny, Dr. Steve Bynon Jr., has been removed from leadership roles in the transplant programs. Patients like Mandy Sears, who has been waiting for a kidney transplant, are left uncertain and concerned about their status amidst the allegations.
Maggie Hengst, a 75-year-old woman from York County, is in need of a kidney due to a rare kidney disease. She and her family are among the few affected by this condition, and after waiting for three years, she is making a plea for a living donor. Hengst hopes that someone will step up to share a spare kidney, as donors do not need to be the same blood type and the procedure is covered by her insurance.
Richard "Rick" Slayman, the first person to receive a successful kidney transplant from a genetically modified pig, has been discharged from the hospital, marking a "new beginning" for him. Slayman, who had been on dialysis for seven years, expressed gratitude to the hospital staff and doctors for their support. The successful surgery is a significant moment in medical history, offering hope for thousands of people in need of organ transplants. Slayman's recovery is progressing smoothly, and he is looking forward to resuming a normal life without the burden of dialysis.
Rick Slayman, the first person to receive a genetically edited pig kidney transplant, has been discharged from the hospital and expressed his joy at the successful surgery. This groundbreaking medical procedure marks a new beginning for him, free from the burden of dialysis, and he is looking forward to resuming a normal life. The transplant, performed at Massachusetts General Hospital, represents a significant advancement in organ transplantation, although it also highlights the risks associated with such pioneering procedures.
Rick Slayman, the first person to receive a genetically modified pig kidney transplant, has been discharged from Massachusetts General Hospital. The successful surgery marks a historic milestone in xenotransplantation and could potentially provide an alternative solution to the global organ shortage. Slayman, who had end-stage kidney disease, expressed gratitude for the exceptional care he received and is excited to resume spending time with his family and loved ones free from the burden of dialysis.
Richard Slayman, the first person to receive a genetically modified pig kidney transplant, has been discharged from the hospital and expressed his excitement at the prospect of resuming a normal life free from the burden of dialysis. The pioneering surgery, which took place on March 16, involved the genetic editing of the pig kidney to increase its compatibility with human recipients. This breakthrough offers hope to millions of patients worldwide suffering from kidney failure and represents a new frontier in organ transplantation.